Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK 30.60
+0.62 (2.07%)
Nov 20, 2024, 5:29 PM CET
Hansa Biopharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -654.78 | -831.72 | -611.13 | -548.28 | -420.85 | -360.01 | Upgrade
|
| Depreciation & Amortization | 10.74 | 10.74 | 9.96 | 6.51 | 7.67 | 6.91 | Upgrade
|
| Other Amortization | 9.05 | 9.05 | 2.09 | 2.09 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.55 | Upgrade
|
| Stock-Based Compensation | 60.64 | 60.64 | 58.23 | 56.62 | 43.35 | 7.25 | Upgrade
|
| Other Operating Activities | -56.69 | -15.8 | 16.69 | -1 | 0.24 | -0.22 | Upgrade
|
| Change in Accounts Receivable | -35.07 | -35.07 | -33.25 | -9.6 | 0.41 | -0.46 | Upgrade
|
| Change in Accounts Payable | 24.49 | 24.49 | 9.12 | 28.58 | -23.9 | 10.15 | Upgrade
|
| Change in Other Net Operating Assets | -58.42 | 22.01 | 45.56 | -16.09 | 102.81 | 1.06 | Upgrade
|
| Operating Cash Flow | -700.03 | -755.65 | -502.73 | -481.17 | -290.27 | -334.78 | Upgrade
|
| Capital Expenditures | 0.29 | -0.28 | -3.33 | -2.4 | -0.29 | -2.7 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.09 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.73 | Upgrade
|
| Investment in Securities | - | - | 232.64 | - | 182.83 | 89.13 | Upgrade
|
| Investing Cash Flow | 0.29 | -0.28 | 229.31 | -2.4 | 182.53 | 85.78 | Upgrade
|
| Long-Term Debt Issued | - | - | 736.4 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 736.4 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -7.55 | -6.89 | -4.86 | -4.67 | -4.42 | Upgrade
|
| Total Debt Repaid | -7.82 | -7.55 | -6.89 | -4.86 | -4.67 | -4.42 | Upgrade
|
| Net Debt Issued (Repaid) | -7.82 | -7.55 | 729.51 | -4.86 | -4.67 | -4.42 | Upgrade
|
| Issuance of Common Stock | 354.31 | - | 415.95 | - | 1,112 | 0.88 | Upgrade
|
| Other Financing Activities | - | - | -27.78 | - | -41.26 | -5.34 | Upgrade
|
| Financing Cash Flow | 346.49 | -7.55 | 1,118 | -4.86 | 1,066 | -8.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.38 | -0.64 | 0.58 | 0.4 | -0.5 | 0.13 | Upgrade
|
| Net Cash Flow | -354.63 | -764.12 | 844.84 | -488.02 | 957.67 | -257.74 | Upgrade
|
| Free Cash Flow | -699.74 | -755.94 | -506.06 | -483.57 | -290.57 | -337.47 | Upgrade
|
| Free Cash Flow Margin | -369.47% | -563.74% | -327.50% | -1427.38% | -4764.97% | -10031.93% | Upgrade
|
| Free Cash Flow Per Share | -11.85 | -14.39 | -11.26 | -10.87 | -6.89 | -8.43 | Upgrade
|
| Cash Interest Paid | 1.02 | 1.02 | 1.17 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.92 | 0.13 | 1.57 | 0.14 | 0.11 | 0.12 | Upgrade
|
| Levered Free Cash Flow | -454.15 | -437.25 | -282.34 | -257.8 | -196.46 | -202 | Upgrade
|
| Unlevered Free Cash Flow | -394.58 | -371.3 | -255.05 | -257.36 | -196.3 | -201.71 | Upgrade
|
| Change in Net Working Capital | 68.83 | -41.37 | -38.07 | -17.04 | -18.65 | -11.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.